Terminal

XBI

154.43

-0.05%

Price

21 sessions shown

1M 3M 6M 1Y 2Y 5Y

Technicals

from daily closes

RSI · 14 day

44.5

Avg true range · 14d

2.75%

Volatility · 20d annualised

25.4%

Trend · 20d vs 50d

—

vs 20-day average

-1.80%

vs 50-day average

—

vs 200-day average

—

200-day average

—

Internals

where it sits, and how hard it is being traded

52-week low

101.01

52-week high

169.89

Volume vs its 20-day avg

—

Beta vs the market

0.86

Sitting 78% of the way up its 52-week range (101.01 → 169.89)

Swings

prices it actually turned at — highest or lowest of the surrounding 11 sessions

Turned down · Sep 23

162.68

Turned up · Sep 16

152.50

Turned up · Sep 24

152.56

Fundamentals

P/E

—

Fwd P/E

—

P/S

—

P/B

—

EV/EBITDA

—

ROE

—

ROA

—

Gross margin

—

Net margin

—

Debt / equity

—

Rev growth

—

EPS growth

—

News

stories naming this company, last 21 days

Better State Street Healthcare ETF: XBI's Biotech Focus vs. XPH Targeting Pharmaceuticals · Yahoo · Oct 4

Biotech Lagged The Broader Market In September — Did Retail Favorites SLS, IBRX, VNDA And IOVA Dodge XBI’s Slump? · Yahoo · Sep 30

Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? · Yahoo · Sep 29

Biotech ETF XBI Hits an Interest Rate Wall as 40+ Catalysts Approach · Benzinga · Sep 25

Biotech: The Party's Over, The Top Is In · SeekingAlpha · Sep 24

VHT vs. XBI: Is Diversified Healthcare Exposure or Biotech Stocks the Smarter Choice for Investors? · Yahoo · Sep 22

Every figure here is measured from live market data as of Oct 4, 05:56 PM. Nothing is estimated or filled in — where a figure shows — the source had no value for it, and a section you don’t see had no data at all. This describes what the market has already done. It is not a forecast, and not financial advice.

← Scan for another See the decision card →